UCLA Als Clinic
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Avila, Gilda
EMAGINE, NCT05044507: The Efficacy of a Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Subacute Ischemic Stroke Patients - a Pivotal Study (THE "" STUDY)

Completed
N/A
100
US
BQ 2.0, BQ 2.0 sham stimulation group, BQ 2.0 active stimulation group
BrainQ Technologies Ltd.
Ischemic Stroke
11/23
01/24
Tiwari, Suchi
MTLE, NCT05135091: FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

Recruiting
1/2
40
US
NRTX-1001, GABA-secreting interneurons, Sham Comparator
Neurona Therapeutics, California Institute for Regenerative Medicine (CIRM)
Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis
05/25
05/26
REFINE-ALS, NCT04259255: Radicava® (Edaravone) Findings in Biomarkers From ALS

Active, not recruiting
N/A
300
Canada, US
Edaravone (Radicava®/Radicava ORS®), Radicava®, Radicava ORS®
Mitsubishi Tanabe Pharma America Inc., Massachusetts General Hospital
Amyotrophic Lateral Sclerosis, ALS
03/24
03/24

Download Options